Evaluation of the Efficacy and Safety of Oral N-acetylcysteine in Patients With COVID-19 Receiving the Routine Antiviral and Hydroxychloroquine Protocol: A Randomized Controlled Clinical Trial

Najmolsadat Atefi; Azadeh Goodarzi; taghi riahi; niloofar khodabandehloo; mahshid talebitaher; niloofar najar nobari; Farnoosh Seirafianpour; zeinab mahdi; amir baghestani; rohollah valizadeh

doi:10.22541/au.170663924.40536518/v1

Evaluation of the Efficacy and Safety of Oral N-acetylcysteine in Patients With COVID-19 Receiving the Routine Antiviral and Hydroxychloroquine Protocol: A Randomized Controlled Clinical Trial

Najmolsadat Atefi, Azadeh Goodarzi, taghi riahi, niloofar khodabandehloo, mahshid talebitaher, niloofar najar nobari, Farnoosh Seirafianpour, zeinab mahdi, amir baghestani, rohollah valizadeh

2024 · doi:10.22541/au.170663924.40536518/v1

preprint OA: closed

📄 Open PDF View at publisher

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

crossref: last seen: 2026-06-11T06:39:56.507817+00:00
europepmc: last seen: 2026-05-20T01:45:00.602351+00:00
unpaywall: last seen: 2026-06-16T06:25:30.133384+00:00